Market Overview

ICYMI: MicroCap Trading Ideas, Puma Biotech, A Valeant Bear Call

Share:
ICYMI: MicroCap Trading Ideas, Puma Biotech, A Valeant Bear Call

In case you missed it, here are some of Benzinga's top stories from Wednesday, Jan. 24, 2018.

A Pharma Trade From Goldman

Jayson Derrick outlines a bull and bear call on Catelent, Inc (NYSE: CTLT) and Valeant Pharmaceuticals International, Inc (NYSE: VRX), respectively, from Goldman Sachs. Check out “Goldman Sachs On Specialty Pharma: Buy Catalent, Sell Valeant.”

Puma Biotech Declawed By European Medicines Agency

Puma Biotechnology, Inc (NASDAQ: PBYI) shares were crushed Wednesday after reporting a negative trend vote from European regulators regarding its neratinib compound. Learn more in Shanthi Rexaline’s “What You Need to Know About Puma Biotech's 25% Slide.”

Related Link: With EU Approval For Puma Biotech's Breast Cancer Drug Unlikely, Cowen Downgrades

'3 Micro-Cap Tech Stocks To Watch In 2018'

Bill Haddad checked out the LD Micro Virtual CES Wrap Up so that you don’t have to. From Vuzix Corporation (NASDAQ: VUZI) to My Size, Inc (NASDAQ: MYSZ), learn why these names are worth keeping an eye on this year.

Latest Ratings for VRX

DateFirmActionFromTo
Jun 2018TD SecuritiesDowngradesBuyHold
Jun 2018BarclaysUpgradesEqual-WeightOverweight
May 2018MizuhoUpgradesNeutralBuy

View More Analyst Ratings for VRX
View the Latest Analyst Ratings

 

Related Articles (VRX + VUZI)

View Comments and Join the Discussion!

Posted-In: Analyst Color Biotech News Previews Small Cap After-Hours Center Analyst Ratings Trading Ideas Best of Benzinga

Latest Ratings

StockFirmActionPT
PLTRWilliam BlairInitiates Coverage On
INECredit SuisseInitiates Coverage On
FLOStephens & Co.Initiates Coverage On25.0
ELSBairdInitiates Coverage On67.0
DDOGTruist SecuritiesInitiates Coverage On120.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com